HUMHumana
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +50% vs its 200-day average.
Lightly shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 8.5% since the previous count, down from 5.2% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How HUM is trading
Humana is +65% over the past year while the S&P 500 is +18%: 46 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +50%
vs 200-day average · a clear uptrend
- RSI (14)
- 69
RSI (14) · neutral
- Below its 52-week high
- 2.8%
Below its 52-week high
Details›
- Last close2026-10-09
- $431.00
- 1 monthS&P 500 +2.7%
- +7.5%
- 1 yearS&P 500 +18%
- +65%
- 5 yearsS&P 500 +88%
- +11%
- vs 50-day average$389.35
- +11%
- 52-week high
- $443.49
- 52-week low
- $162.84
- Annualised volatility
- 48%
| Year | Return |
|---|---|
| 2026 (year to date) | +69% |
| 2025 | +2.4% |
| 2024 | −44% |
| 2023 | −9.9% |
| 2022 | +11% |
| 2021 | +14% |
| 2020 | +13% |
| 2019 | +29% |
| 2018 | +16% |
| 2017 | +23% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | −3.7% |
| Feb | 10 | 2 of 10 | −2.1% |
| Mar | 10 | 2 of 10 | −1.3% |
| Apr | 10 | 7 of 10 | +7.5% |
| May | 10 | 5 of 10 | +3.9% |
| Jun | 10 | 8 of 10 | +3.1% |
| Jul | 11 | 7 of 11 | +1.7% |
| Aug | 11 | 6 of 11 | +3.3% |
| Sep | 11 | 3 of 11 | −3.3% |
| Oct | 11 | 7 of 11 | +4.6% |
| Nov | 10 | 6 of 10 | +3.0% |
| Dec | 10 | 4 of 10 | −2.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.